Sentence examples for acquisition of therapy from inspiring English sources

Prior research has demonstrated that medication persistence (continued acquisition of therapy over time) is far from optimal among patients with glaucoma.

Similarly, acquisition of therapy resistance is believed to depend on the selection of subclones exhibiting activation of the respective resistance mechanisms (Bredel, 2001).

In particular, centers were responsible for covering the costs involved in the acquisition of the VNS therapy device.

Experimental and clinical data suggest that the EMT has an important role in the generation of CTCs and the acquisition of resistance to therapy.

We estimated the costs of therapy acquisition using the average sales price (ASP) for the entire duration of UOL therapies, a statutorily defined price based on the national average of manufacturers' sales prices from two earlier quarters plus a 6% margin [ 21].

In the treatment of community-acquired pneumonia (CAP), several initial processes of care have been associated with improved survival, including the timely delivery and appropriate selection of antibiotic therapy, and acquisition of blood cultures prior to initiating antibiotic therapy [ 8- 11].

Perhaps, the most convincing evidence for progress with a novel endocrine therapy combination would be an enhanced rate of pCR as evidence for the activation of a cell death process that would more effectively delete ER+ breast cancer cells before the acquisition of resistance to endocrine therapy (Crowder et al, 2009) or an increased rate of PEPI score 0 following neoadjuvant therapy.

If DOT is not more effective for managing tuberculosis than is self-supervision of therapy, then acquisition and transmission of drug resistant strains should be similar in both counties.

Levels of pFAK and pSrc were dramatically higher upon acquisition of resistance to LT therapy, and they were markedly reduced by treatment with AIIB2.

Acquisition of resistance to endocrine therapy remains a major problem in the treatment of ER + breast cancer and using inhibitors to target de-regulated growth factor signalling pathways, such as mTOR, has become an important therapeutic approach currently under intense clinical evaluation.

PFS was defined as the time interval from the date of imatinib therapy induction until tumor progression, end of therapy, or data acquisition.